Business Context and Reporting Period
Company: Atyr Pharma, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: May 21, 2019
Reporting Period: Single event date (May 21, 2019)
Business Context: The Company entered into a Common Stock Sales Agreement to establish an "at-the-market" equity offering program.
Key Financial Metrics
This filing does not contain periodic financial statements (e.g., revenue, profit, cash flow, or margins). The only financial metric disclosed relates to the new equity program:
- Maximum Offering Size: Up to $10,000,000 in aggregate offering price.
- Commission Rate: 3.0% of gross proceeds per share sold.
- Debt and Liquidity: The filing text does not provide a clear value for current debt levels or liquidity positions.
Material Changes
The material change reported is the execution of a definitive agreement with H.C. Wainwright & Co., LLC. This agreement authorizes the Company to sell shares of its common stock through an at-the-market offering program. There are no reported changes to prior period financial results as this is a current event report.
Guidance, Outlook, and Risks
Management Commentary: The Company has no obligation to sell any shares under the agreement and retains the right to suspend offers or terminate the agreement at any time. Sales will be made pursuant to an effective Form S-3 registration statement.
Risks and Contingencies:
- Sales are subject to market conditions and the Company's instructions.
- Offers are subject to securities laws and registration requirements in specific states.
- The agreement includes customary indemnification rights for the agent.
Investor Verification Checklist
- Verify the current cash position and burn rate to assess the necessity of the $10 million equity raise.
- Review the effective Form S-3 (File No. 333-211998) referenced in the filing for full terms.
- Monitor future 8-K filings for actual sales volumes and proceeds generated under the program.
- Assess potential dilution impact on existing shareholders if the full $10 million is sold.